TrialScientific reports2018

Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis.

Samer Al-Dury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.